The Clinical and Translational Toxicology Specialty Section (CTTSS) is a subgroup of the Society of Toxicology, the membership of which has expertise in all aspects of clinical and translational toxicology. Members interested in the impact of pharmaceuticals, chemicals, plant and fungi toxins, and terrestrial and marine animal venoms on human health can share their knowledge and propose new approaches for the treatment of these exposures, based on an understanding of their mechanisms of toxicity. The CTTSS will stimulate discussion on the optimal regimens for treatment based on a detailed understanding of the toxicokinetics and toxicodynamics of the agent involved and the pharmacology and adverse effects of the proposed treatment. The CTTSS is committed to improving the management of human poisoning by using a translational approach that links molecular mechanisms to rational therapy. The image of calcium oxalate crystals (the underlying cause of ethylene glycol nephrotoxicity) featured on our title page and kindly donated by one of our section’s founding members, Prof. Kenneth McMartin, is a great example of how translational toxicology best traces the path from theories at the bench to treatments at the bedside. You can read more about the origins of CTTSS and our logo which includes the structure of fomepizole (the antidote for ethylene glycol poisoning).
CTTSS holds regular meetings at the SOT Annual Meetings to discuss topics of interest to the membership.
The elected officials consist of the President, Vice President, Vice President-Elect, Secretary/Treasurer, and two Councilors. For a current listing of the CTTSS Officers, view Executive Commitee.